ad image
Five Small Biotechs to Watch: April 2025
Biotechs
Mar 31, 2025

Five Small Biotechs to Watch: April 2025

This latest installment profiles five emerging biotech startups — Ignota Labs, Model Medicines, LinkGevity, Nanograb, and Ångström AI — that are leveraging artificial intelligence to revolutionize drug discovery, from repurposing failed compounds to designing novel therapeutics and optimizing targeted delivery.

Bridging Innovation and Manufacturing for Complex Injectables
Complex Injectables
Apr 18, 2025

Bridging Innovation and Manufacturing for Complex Injectables

ForDoz Pharma bridges the gap between innovative formulation science and scalable manufacturing to accelerate the development and commercialization of complex injectable therapies like microspheres, liposomes, and depot systems.

Employees Who Think Like Stakeholders: The Power of Transparency and Empowerment
Financial Literacy
Mar 14, 2025

Employees Who Think Like Stakeholders: The Power of Transparency and Empowerment

Emilee Kudla reimagines what a business could look like if collaboration, transparency, and shared success were actually built into the foundation.

The White House’s War on the NIH and the Disasters Ahead
NIH
Mar 24, 2025

The White House’s War on the NIH and the Disasters Ahead

Now is the time for scientists, policymakers, and the public to unite in defense of the NIH and the future of scientific integrity.

Strategic Biomanufacturing Partner for Multispecific Antibodies
Multispecific Abs
Apr 14, 2025

Strategic Biomanufacturing Partner for Multispecific Antibodies

Samsung Biologics' Youngsun Kim, Jina Kim, and Busol Park discuss how Samsung Biologics leverages seven strategic pillars to overcome the scientific, technical, and regulatory challenges of multispecific antibody development and manufacturing.

Beyond the Binary: Including Trans and Non-Binary Individuals in Clinical Research
Trans and Non-Binary
Apr 10, 2025

Beyond the Binary: Including Trans and Non-Binary Individuals in Clinical Research

Clinical research must evolve to meaningfully include transgender and non-binary individuals, and equity and scientific rigor demand structural change at every stage of the research process.

DNA Nanobots: Precision Machines at the Molecular Frontier
DNA Nanobots
Apr 04, 2025

DNA Nanobots: Precision Machines at the Molecular Frontier

Editor in Chief David Alvaro, Ph.D., explores how DNA nanobots — self-assembling, programmable molecular machines — are poised to transform medicine, environmental science, and nanomanufacturing through precision-targeted interventions and groundbreaking innovations.

Spintronics and the Future of Drug Design
Spintronics
Apr 04, 2025

Spintronics and the Future of Drug Design

Editor in Chief David Alvaro, Ph.D., discusses how spintronics — the manipulation of electron spin for information processing — is poised to revolutionize drug design, diagnostics, and targeted therapy in biomedicine through quantum-level precision and magnetic control.

Unlocking the Potential of Psychedelics for Postpartum Depression
Psychedelics
Mar 31, 2025

Unlocking the Potential of Psychedelics for Postpartum Depression

In this Q&A, Reunion Neuroscience President and CEO Greg Mayes discusses RE104, a novel prodrug designed to offer the benefits of psilocybin with a shorter duration and improved pharmacokinetics in clinical studies for postpartum depression.

From Space to Sight: Leveraging Microgravity to Enhance Artificial Retina Technology
Low Earth Orbit
Apr 04, 2025

From Space to Sight: Leveraging Microgravity to Enhance Artificial Retina Technology

LambdaVision is harnessing the transformative potential of microgravity aboard the International Space Station to revolutionize artificial retina manufacturing.

Recommended

Public Statement on Supporting Science for the Benefit of All Citizens
Open Letter
Mar 31, 2025
Public Statement on Supporting Science for the Benefit of All Citizens
Manufacturing Nanomaterials in Space to Treat Disease on Earth
Space
Apr 17, 2025
Manufacturing Nanomaterials in Space to Treat Disease on Earth
Nelson Labs Celebrates 40 Years of Excellence in Science and Service
Anniversary
Apr 17, 2025
Nelson Labs Celebrates 40 Years of Excellence in Science and Service

Spotlight

Conversations with Carleone: Leadership Wisdom Worth Sharing
Employees Who Think Like Stakeholders: The Power of Transparency and Empowerment
The Valuation Equation: Speculating on Why Marketing and Communication Might Matter More than You Think
Five Small Biotechs to Watch: March 2025
ad image
ad image

THAT'S NICE TURNS 30: THREE DECADES OF BIOPHARMA AND THE ROAD TO THE FUTURE

featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content

Nice Insights

Expanding the Frontiers of Cell Therapy: Veterinary Applications and Translational Insights
Cell Therapy
Mar 26, 2025
Expanding the Frontiers of Cell Therapy: Veterinary Applications and Translational Insights
Is mRNA a Gene Therapy? Unpacking the Evolving Regulatory Debate
RNA
Mar 26, 2025
Is mRNA a Gene Therapy? Unpacking the Evolving Regulatory Debate
Science Under Siege: The Devastating Consequences of Public Health and Research Cuts
Federal Job Cuts
Feb 19, 2025
Science Under Siege: The Devastating Consequences of Public Health and Research Cuts
Employees Who Think Like Stakeholders: The Power of Transparency and Empowerment
Financial Literacy
Mar 14, 2025
Employees Who Think Like Stakeholders: The Power of Transparency and Empowerment
Beyond the Binary: Including Trans and Non-Binary Individuals in Clinical Research
Trans and Non-Binary
Apr 10, 2025
Beyond the Binary: Including Trans and Non-Binary Individuals in Clinical Research
The End of an Era: What the FDA's Move Away from Animal Testing Means for Biopharma
Animal Testing
Apr 14, 2025
The End of an Era: What the FDA's Move Away from Animal Testing Means for Biopharma
Conversations with Carleone: Leadership Wisdom Worth Sharing
Leadership Wisdom
Mar 14, 2025
Conversations with Carleone: Leadership Wisdom Worth Sharing
Boolean Biology: The Future of Logic-Gated Cell and Gene Therapies
LOGIC GATES
Mar 14, 2025
Boolean Biology: The Future of Logic-Gated Cell and Gene Therapies
Magnetogenetics and the Future of Remote Biological Control
Magnetogenetics
Mar 17, 2025
Magnetogenetics and the Future of Remote Biological Control
Spintronics and the Future of Drug Design
Spintronics
Apr 04, 2025
Spintronics and the Future of Drug Design
DNA Nanobots: Precision Machines at the Molecular Frontier
DNA Nanobots
Apr 04, 2025
DNA Nanobots: Precision Machines at the Molecular Frontier
Rewriting the Script: The Past, Present, and Future of RNA Editing Therapeutics
RNA Editing
Apr 18, 2025
Rewriting the Script: The Past, Present, and Future of RNA Editing Therapeutics
ad image

IMPACT

#1

NIH

The White House’s War on the NIH and the Disasters Ahead
#2
#3
#4
#5
ad image

Roundtable

View all roundtable
ad image

Editor's Picks

Maternal Mandate: Elevating Innovation, Equity, and Investment in Women’s Health
Maternal Health
Apr 08, 2025
Maternal Mandate: Elevating Innovation, Equity, and Investment in Women’s Health
Unlocking the Potential of Psychedelics for Postpartum Depression
Psychedelics
Mar 31, 2025
Unlocking the Potential of Psychedelics for Postpartum Depression
Beyond the Binary: Including Trans and Non-Binary Individuals in Clinical Research
Trans and Non-Binary
Apr 10, 2025
Beyond the Binary: Including Trans and Non-Binary Individuals in Clinical Research
Boolean Biology: The Future of Logic-Gated Cell and Gene Therapies
LOGIC GATES
Mar 14, 2025
Boolean Biology: The Future of Logic-Gated Cell and Gene Therapies
Employees Who Think Like Stakeholders: The Power of Transparency and Empowerment
Financial Literacy
Mar 14, 2025
Employees Who Think Like Stakeholders: The Power of Transparency and Empowerment
Conversations with Carleone: Leadership Wisdom Worth Sharing
Leadership Wisdom
Mar 14, 2025
Conversations with Carleone: Leadership Wisdom Worth Sharing
Rewriting the Script: The Past, Present, and Future of RNA Editing Therapeutics
RNA Editing
Apr 18, 2025
Rewriting the Script: The Past, Present, and Future of RNA Editing Therapeutics
Science Under Siege: The Devastating Consequences of Public Health and Research Cuts
Federal Job Cuts
Feb 19, 2025
Science Under Siege: The Devastating Consequences of Public Health and Research Cuts
NIH Funding Cuts Put Innovation, Health Equity, and Lives at Risk
NIH Funding
Feb 10, 2025
NIH Funding Cuts Put Innovation, Health Equity, and Lives at Risk
The End of an Era: What the FDA's Move Away from Animal Testing Means for Biopharma
Animal Testing
Apr 14, 2025
The End of an Era: What the FDA's Move Away from Animal Testing Means for Biopharma
Five Small Biotechs to Watch: March 2025
Small Biotechs
Feb 28, 2025
Five Small Biotechs to Watch: March 2025
Magnetogenetics and the Future of Remote Biological Control
Magnetogenetics
Mar 17, 2025
Magnetogenetics and the Future of Remote Biological Control
ad image

Videos

View all videos
Diagnostics
Nov 15, 2024

Better Outcomes for Cancer Patients Begin with Screening

Jayne Shaw, Co-Founder and Executive Chair of BCAL Diagnostics, a biotechnology company focused on improving breast cancer screening and diagnostics, shares BCAL’s mission to provide early and accurate diagnoses, enabling timely intervention and better health outcomes for women.

Better Outcomes for Cancer Patients Begin with Screening
Diagnostics
Nov 15, 2024
Better Outcomes for Cancer Patients Begin with Screening
Navigating the Australian Clinical Trials Landscape
Commissioning
Nov 15, 2024
Navigating the Australian Clinical Trials Landscape
Translating Academic Pursuits into Real-World Applications
Research
Nov 15, 2024
Translating Academic Pursuits into Real-World Applications
Shining Light on the Communicable Disease Plight in Australia's Koalas
Koalas
Nov 15, 2024
Shining Light on the Communicable Disease Plight in Australia's Koalas
Leaps and Bounds for Synthetic Biology Startups
Synthetic Biology
Nov 15, 2024
Leaps and Bounds for Synthetic Biology Startups
Queensland University of Technology's Cutting-Edge Synthetic Biology Lab
Synthetic Biology
Nov 15, 2024
Queensland University of Technology's Cutting-Edge Synthetic Biology Lab
Four Decades of Innovation: An Interview with Joseph Carleone
Leadership
Apr 16, 2025
Four Decades of Innovation: An Interview with Joseph Carleone
State-of-the-Art, Multi-Modality Bioanalysis in Brisbane
Bioassays
Nov 12, 2024
State-of-the-Art, Multi-Modality Bioanalysis in Brisbane
QBI is Helping Translate Brain Research into Treatments
Neuroscience
Nov 15, 2024
QBI is Helping Translate Brain Research into Treatments
Building on Australia's Existing Biopharma Infrastructure
Biotherapeutics
Nov 15, 2024
Building on Australia's Existing Biopharma Infrastructure
Primal Organix's Nutraceutical Approach to Better Mental Health
Terpenes
Nov 12, 2024
Primal Organix's Nutraceutical Approach to Better Mental Health
Advancing Personalized Medicines and Precision Therapeutics
Precision Medicine
Nov 15, 2024
Advancing Personalized Medicines and Precision Therapeutics

Latest

View all latest
RNA Editing
Apr 18, 2025
Rewriting the Script: The Past, Present, and Future of RNA Editing Therapeutics
Complex Injectables
Apr 18, 2025
Bridging Innovation and Manufacturing for Complex Injectables
Leadership
Apr 16, 2025
Four Decades of Innovation: An Interview with Joseph Carleone
Oncology
Apr 15, 2025
From Chemo to Advanced Therapies: New Frontiers in Oncology
Protein Design
Apr 15, 2025
Reprogramming the Rules: How AI Is Transforming De Novo Protein Design in Drug Development
Analytical
Apr 15, 2025
Leveraging Advanced GMP Release and Stability Testing Methods to Accelerate New Drug Development
AI and Gender
Apr 14, 2025
The Gender Bias Built Into AI — And Its Threat to Women’s Health
Gene Therapy
Apr 14, 2025
Gene Therapy at 30: Milestones, Setbacks, and a Path Forward
ad image
ad image
Mammailan cell culture,Biologics: Market Insight, CDMO Pricing and Competitor Benchmarking

Mammailan cell culture,Biologics: Market Insight, CDMO Pricing and Competitor Benchmarking

LEARN MORE
Microbial Fermentation, Biologics: Market Insight, CDMO Pricing and Benchmarking

Microbial Fermentation, Biologics: Market Insight, CDMO Pricing and Benchmarking

LEARN MORE
Antibody–Drug Conjugate, ADC: Market Insight, CDMO Pricing and Competitor Benchmarking

Antibody–Drug Conjugate, ADC: Market Insight, CDMO Pricing and Competitor Benchmarking

LEARN MORE
Sterile Fill Finish: Market Insight, CDMO Pricing and Competitor Benchmarking

Sterile Fill Finish: Market Insight, CDMO Pricing and Competitor Benchmarking

LEARN MORE
Gene Therapy: Market Insight, CDMO Pricing and Competitor Benchmarking

Gene Therapy: Market Insight, CDMO Pricing and Competitor Benchmarking

LEARN MORE
Cell Therapy: Market Insight, CDMO Pricing and Competitor Benchmarking

Cell Therapy: Market Insight, CDMO Pricing and Competitor Benchmarking

LEARN MORE
Messenger Ribonucleic Acid, mRNA: Market Insight, CDMO Pricing and Competitor Benchmarking

Messenger Ribonucleic Acid, mRNA: Market Insight, CDMO Pricing and Competitor Benchmarking

LEARN MORE
Plasmids Market Insight, CDMO Pricing and Competitor Benchmarking

Plasmids Market Insight, CDMO Pricing and Competitor Benchmarking

LEARN MORE
Active Pharmaceutical Ingredients, API: Market Insight, CDMO Pricing and Competitor Benchmarking

Active Pharmaceutical Ingredients, API: Market Insight, CDMO Pricing and Competitor Benchmarking

LEARN MORE
Oral Solid Dose, OSD: Market Insight, CDMO Pricing and Benchmarking

Oral Solid Dose, OSD: Market Insight, CDMO Pricing and Benchmarking

LEARN MORE

Subscribe for the Newsletter

Pharma’s Almanac’s weekly newsletter, featuring industry news and must-read original content on a range of topics.

The Road To Series

030db6fe-32bf-4364-88b0-28655c88acf9
ea932e33-29ac-48c3-9e59-fea0994b10cc
cfe49a93-d81b-451e-9e07-8ba4ebfc53b8
8887a25b-41b6-430d-8d52-9722c7334914
2c58207c-1481-4629-bd23-de0d0815f2b1
e6bf6f4c-ce04-4ec3-9aa9-6c34b1c2494f